The Staff of the Division of Corporation Finance at the Securities and Exchange Commission (SEC) has recently begun issuing comment letters in the life sciences reverse merger (RM) context that involve a broadened...more
1/22/2024
/ Capital Formation ,
Compliance ,
Form 8-K ,
Form S-1 ,
Life Sciences ,
Mergers ,
Publicly-Traded Companies ,
Recapitalization ,
Resales Agreements ,
Reverse Mergers ,
Rule 144 ,
SEC Comment Letter Process ,
Securities and Exchange Commission (SEC) ,
Shell Corporations
We recently represented Klaviyo, Inc. (NYSE: KVYO), in its $576 million initial public offering on the New York Stock Exchange. As has been extensively reported in the media, Klaviyo’s very successful offering represented the...more
10/30/2023
/ Articles of Incorporation ,
Common Stock ,
Corporate Governance ,
Delaware General Corporation Law ,
Form S-1 ,
Glass Lewis ,
Initial Public Offering (IPO) ,
Institutional Investors ,
Institutional Shareholder Services (ISS) ,
Jurisdiction ,
Share Classes ,
Stocks ,
Strategic Planning ,
Venture Capital